Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL2108575
Created by
admin on Mon Mar 31 23:04:06 GMT 2025 , Edited by admin on Mon Mar 31 23:04:06 GMT 2025
|
PRIMARY | |||
|
300000021838
Created by
admin on Mon Mar 31 23:04:06 GMT 2025 , Edited by admin on Mon Mar 31 23:04:06 GMT 2025
|
PRIMARY | |||
|
Aselizumab
Created by
admin on Mon Mar 31 23:04:06 GMT 2025 , Edited by admin on Mon Mar 31 23:04:06 GMT 2025
|
PRIMARY | |||
|
C171823
Created by
admin on Mon Mar 31 23:04:06 GMT 2025 , Edited by admin on Mon Mar 31 23:04:06 GMT 2025
|
PRIMARY | |||
|
395639-53-9
Created by
admin on Mon Mar 31 23:04:06 GMT 2025 , Edited by admin on Mon Mar 31 23:04:06 GMT 2025
|
PRIMARY | |||
|
8291
Created by
admin on Mon Mar 31 23:04:06 GMT 2025 , Edited by admin on Mon Mar 31 23:04:06 GMT 2025
|
PRIMARY | |||
|
8Y539D78FU
Created by
admin on Mon Mar 31 23:04:06 GMT 2025 , Edited by admin on Mon Mar 31 23:04:06 GMT 2025
|
PRIMARY |
ACTIVE MOIETY